Rick Simpson Oil (RSO) in Bryan County, Georgia: The Complete Guide by OilWell Cannabis

Living in Bryan County means understanding resilience. Whether you’re navigating the daily commute from Richmond Hill into Savannah, supporting loved ones at Fort Stewart, or managing the quiet challenges of rural life in Pembroke and the unincorporated communities that dot our landscape, we know what it means to keep going when conventional solutions fall short. That’s why we’re here — to talk honestly about Rick Simpson Oil (RSO), what it actually is, what the science really says, and how a modern, legal formulation can serve our Bryan County community.

Understanding Rick Simpson Oil: Why This Matters in Bryan County

If you’re reading this from your home near the Ogeechee River, from a porch in Ellabell, or while waiting at the VA clinic in Hinesville, you may have heard about RSO through word-of-mouth at the hardware store, in a caregiver support group at First Baptist, or from a fellow veteran at the VFW post. The term “RSO” has become one of the most searched cannabis-related terms across Southeast Georgia, including right here in Bryan County. But what most people don’t realize is that what’s sold as “RSO” today often bears little resemblance to what Rick Simpson actually created — and that difference matters for your health, your safety, and your wallet.

Who Was Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. His story resonates across Bryan County because we’ve all known someone — a logger with chronic back pain, a veteran with TBI symptoms, a farmer with arthritis — who was told there were no more options.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications prescribed either failed to help or made his condition worse. Sound familiar? We’ve all heard similar stories at Bryan County medical offices — patients cycled through ineffective prescriptions while being told that their only option is to live with the pain.

When Simpson asked his physician to consider cannabis, the request was refused. This refusal — this institutional dismissal — became the catalyst for everything that followed. Simpson learned about a 1974 NIH study at the Medical College of Virginia where THC was reported to slow tumors in mice. That study, originally intended to demonstrate harm, became his foundational reference. Important context: those findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No independent medical verification, no biopsy confirmation, no clinical follow-up has ever been published in any peer-reviewed source. This personal testimony, however, became the origin story of Rick Simpson Oil and the foundation of a global movement.

For Bryan County residents: We understand why this story matters here. When you’re facing a two-hour drive to Savannah for a specialist appointment, or when the specialist says “there’s nothing more we can do,” stories like Simpson’s offer a glimmer of hope. Our job is to honor that hope while giving you the honest, evidence-based information you need to make informed decisions.

The Crusade: Spreading the Oil Across Borders and Communities

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others in his community. He charged nothing. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which showed testimonials from people he had treated. The film became foundational in cannabis communities worldwide — and undoubtedly reached some in Bryan County through online forums or patient support groups.

But his advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada for Europe, living in Croatia and later the Netherlands, continuing his advocacy from abroad.

In 2012, he published Phoenix Tears: The Rick Simpson Story, documenting his experience, oil-making process, and philosophical views on institutional suppression. He maintained phoenixtears.ca as his primary platform.

Throughout his public career, Simpson maintained an uncompromising position: cannabis oil could cure cancer and many other diseases, and pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect financial interests. He framed his work as fighting institutional corruption.

Important context: Simpson’s conspiratorial framing is noted here without endorsement. It reflects a worldview shared by many in the early cannabis movement and is relevant to understanding RSO’s cultural significance. Our goal at OilWell is to present the evidence honestly, not to promote or dismiss any worldview.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over approximately 90 days. This protocol is still circulated in cancer support groups and online forums that Bryan County residents may encounter.

Goal: Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days.

Titration Schedule:

• Week 1: Begin with a dose the size of half a grain of dry rice (approximately 10-15 mg of oil) taken three times daily. Total daily intake: 30-45 mg.
• Weeks 2-5: Double the dose approximately every four days. By the end of this phase, reach approximately 1 gram (1,000 mg) of oil per day, divided into three doses.
• Weeks 5-12: Maintain the full dose of approximately 1 gram per day (≈333 mg per dose) until all 60 grams are consumed.

Administration Methods:

• Primary: Oral ingestion (sublingual or swallowing) for systemic absorption.
• Secondary: Topical application for skin cancers and external lesions.
• Not Recommended: Inhalation as a primary treatment method.

Tolerance and Psychoactive Effects:

• Simpson claimed patients develop significant THC tolerance within 3-4 weeks.
• He considered euphoric or sedating effects minor and temporary.
• Recommended initial nighttime dosing to sleep through the most intense psychoactive effects.
• Warned against driving or operating machinery during titration.

Post-Protocol Maintenance: After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely for cancer prevention.

Important Context for Evaluating This Protocol:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or well-documented case series support this protocol for any cancer type or condition.
• Assumes crude, unstandardized material. Actual THC content varied widely depending on starting plant material and extraction technique.
• Very high THC exposure. At peak dosing, patients consumed roughly 600-900 mg of delta-9 THC daily — far exceeding anything studied in controlled clinical settings. For context, FDA-approved dronabinol is typically dosed at 2.5-20 mg per day.
• Real risks at these doses. Consuming 600-900 mg of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder.
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment — potentially in place of proven therapies — introduces genuine harm.

What Traditional RSO Actually Was: The Product

Source Material: Single high-THC indica strains, with no strain standardization. Whatever was available locally.

Extraction Solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens.

Extraction Process: Bucket, solvent, agitate, filter, rice cooker evaporation, syringes. High heat destroyed terpenes and fully decarboxylated THCa into THC.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile: THC-dominant (60-90% estimated), fully decarboxylated, with minor cannabinoids at natural, uncontrolled ratios. No lab verification.

Terpene Content: Minimal to none. The solvent + heat process stripped them all.

Standardization and Testing: None. Every batch was different. No COA, no cannabinoid quantification, no contaminant screening.

Residual Solvent Risk: Significant. Incomplete solvent purging is difficult to verify without lab testing and leaves potentially harmful residues.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. Let’s examine what the evidence actually shows.

What Simpson Was Not:

• Not a scientist, physician, pharmacologist, or researcher
• No formal training in medicine, oncology, or clinical research methodology
• Never designed, conducted, funded, or published a clinical trial
• Never submitted results to peer review
• Evidence base consisted entirely of personal experience and informal testimonials with no controls, verification, or long-term follow-up

What the Preclinical Literature Shows:

• In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines
• Animal models show some tumor-growth inhibition in mice and rats
• These findings are scientifically interesting and have generated legitimate research interest

What the Preclinical Literature Does NOT Show:

• These findings have NOT translated into proven human cancer cures
• The gap between animal results and human clinical outcomes is vast
• No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer

Institutional Positions:

• U.S. National Cancer Institute: Acknowledges cannabinoids have been studied for potential anticancer effects in lab and animal models but does NOT endorse cannabis or cannabis oil as a cancer treatment.
• U.S. Food and Drug Administration: Has NOT approved any cannabis plant product for cancer treatment. Only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea/AIDS wasting are approved.
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: States strongest evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite — NOT cancer cure.

What Simpson Got Right:
He drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. His advocacy helped create the political and cultural conditions for the legal cannabis industry and research infrastructure that exists today. He brought concentrated cannabis oil to widespread public awareness.

What He Overstated:
The leap from preclinical signals to cancer cure was not supported by human evidence then, and it is not supported now. Encouraging patients to rely on RSO as a primary treatment in place of proven oncologic therapies carries genuine harm potential.

Why This Matters for Bryan County

Bryan County residents facing cancer diagnoses often travel to the Nancy N. and J.C. Lewis Cancer & Research Pavilion in Savannah or the Curtis and Elizabeth Anderson Cancer Institute at Memorial Health. When oncologists present standard protocols, some patients seek alternatives. We understand. But delaying or foregoing proven treatment for an unproven alternative can cause irreversible harm.

Our position is clear: RSO education complements medical care; it does not replace it. If you’re a Bryan County resident considering RSO, please:

1. Discuss it with your oncologist at your next appointment in Savannah or Statesboro
2. Contact the Southeast Georgia Health System patient navigator
3. Reach out to local support groups like the Bryan County Cancer Support Network
4. Make informed decisions based on evidence, not hope alone

About OilWell Cannabis: Our Story

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But this isn’t a corporate story — it begins where many Bryan County stories do: in a place of hardship, survival, and love.

From the Borderplex to Bryan County

Colin grew up in McAllen, Texas — right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. It shares some DNA with parts of rural Georgia — places where opportunity is scarce, where you learn to hustle young, and where your best friends sometimes don’t make it out.

By sixteen, after experiencing every form of violence imaginable, Colin had to leave home for good. Despite the dangers, he didn’t fall into darker paths. He chose cannabis, seeing it as a safer, more beneficial alternative. He learned the plant intimately in the traditional cannabis world, long before legalization.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine — one of the most prestigious medical institutions in the Texas Medical Center. That combination of deep cannabis plant knowledge and medical-grade technical precision defines everything we do.

Bentley: The Dog Who Started Everything

Our company’s origin story begins with a dog named Bentley. Bentley was more than a pet — he was family. When veterinarians delivered the verdict no owner wants to hear — euthanasia was the only humane option — Colin refused to accept it. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering.

In a desperate search for alternatives, a rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything.

Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It wasn’t a cure, but it was hope. And that hope delivered what veterinary medicine said was impossible: Bentley got up, walked over, and brought Colin his ball to play. Dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → led to CBC’s role in neurogenesis
• Glaucoma → led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. The pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Journey: PTSD and Benzo Withdrawal

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Doctors Use Our Formulas

Over time, the therapeutic benefits of cannabis that Colin first discovered through Bentley became the core of our work. We’ve developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Our Commitment to Bryan County

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas.

But here’s what matters for you in Bryan County: We can serve you. We ship nationwide. We deliver same-day in Houston, but for our Bryan County customers in Richmond Hill, Pembroke, Keller, and all the communities in between, we offer fast, discreet shipping directly to your door.

The OilWell RSO Philosophy: Four Core Principles

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality.

For Bryan County residents, this is critical. Georgia’s medical marijuana program is one of the most restrictive in the country. You need a qualifying condition, a doctor’s prescription, and you’re limited to Low-THC oil from one of only a handful of dispensaries — none in Bryan County. The nearest is in Savannah or Macon, requiring you to drive hours and pay premium prices.

With OilWell, you order from your home in Bryan County, and we ship directly to you. No doctor’s appointment. No state registry. No qualifying condition list. Just legal, Farm Bill-compliant hemp-derived products available to any adult Georgian who wants to try them responsibly.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency.

For Bryan County residents who work at the Port of Savannah, drive trucks for a living, operate farm equipment, or simply need to function mentally clear during the day, this matters tremendously. You can use the raw formula during working hours with zero impairment, then activate it at home in the evening for full therapeutic strength.

Three usage options:

• Raw (no heat): Non-psychoactive, compatible with work, driving, and parenting
• Fully activated (home decarb): Heat at 260°F for 45-60 minutes converts 1,500mg THCa → ~1,315mg delta-9 THC for full potency
• Vape (auto-decarb): Instant conversion at 400-450°F for rapid relief

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version.

For Bryan County’s economically diverse communities, this is revolutionary. Not everyone in Keller or Black Creek can afford $129.99 for a bottle of RSO. But everyone can see exactly what’s in it and, if they have the means and knowledge, create their own version using the same ratios.

This is a direct echo of Rick Simpson’s original ethos. He gave his oil away for free and taught people how to make it. We adapted that for the modern cannabinoid marketplace: sell a professionally manufactured, lab-tested, standardized product for those who want it, and publish the complete recipe for those who want to make it themselves.

The formula that saved Bentley (published free):

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions: Mix turmeric and water over low heat until paste forms (7-10 minutes). Add coconut oil and pepper. Cool, store refrigerated up to two weeks. Mix with pet’s food.

This recipe — published years before our RSO formulas — demonstrates that our open-source ethos is foundational behavior, not marketing strategy.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section of this document represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature or clinical trial data. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

For Bryan County residents making health decisions, this honesty is everything. You deserve to know exactly what the evidence supports and what it doesn’t.

Farm Bill Compliance and Legal Framework for Bryan County, Georgia

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Georgia Context: Georgia’s Hemp Farming Act aligns with federal law, allowing hemp-derived cannabinoids with <0.3% delta-9 THC. However, Georgia’s marijuana laws remain strict. Recreational marijuana is illegal, and the medical marijuana program is extremely limited.

OilWell’s RSO Sublingual Oil contains only 90mg of delta-9 THC in the entire 30mL bottle — 3mg per mL — well under the 0.3% threshold. All cannabinoids are hemp-derived.

THCa Distinction: THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale. This distinction is legally significant for Bryan County customers.

Practical Impact: You can legally purchase, possess, and use our product throughout Bryan County, Pembroke, Richmond Hill, and all of Georgia. You can also legally transport it across state lines, though you should verify laws in any state you travel to.

Customer Responsibility: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with local laws after decarboxylation. We ship with full documentation, Certificates of Analysis, and receipts for your protection.

Our Products: Complete Specifications

RSO Sublingual Oil — $129.99

Complete Formula (Open-Source):

• CBD: 4,500mg
• CBG: 3,000mg
• Delta-8 THC: 6,000mg
• THCa: 1,500mg
• Delta-9 THC: 90mg
• CBN: 750mg
• CBC: 750mg
• TOTAL CANNABINOIDS: 16,590mg

Additional Specifications:

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Carrier: Organic MCT oil
• Dosing: Graduated dropper with 0.1mL increments
• Onset: 15-45 minutes (sublingual)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: Approximately 40-60 depending on serving size

RSO Vape Cartridge — $49.99

Complete Formula (Open-Source):

• CBD: 30%
• CBG: 20%
• Delta-8 THC: 15%
• THCa: 10%
• CBN: 10%
• CBC: 10%
• Live Terpenes: 5%+
• Format: 1-gram cartridge
• 510-thread: Universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation: At 400-450°F, THCa converts instantly to delta-9 THC

When to Use Each Format:

Use Case	Recommended Format	Why
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability/discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	0.1mL graduated dropper
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Condition-Specific Usage Context for Bryan County Residents

Important Disclaimer: The following contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products have NOT been evaluated by the Food and Drug Administration and are NOT intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have health concerns. Do NOT operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For Bryan County patients traveling to Savannah’s Lewis Cancer Pavilion or the Anderson Cancer Institute:

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Evidence: Delta-8 THC antiemetic properties [9], delta-9 THC for nausea/vomiting [1][13], CBD for anxiety buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

For Bryan County residents dealing with the physical toll of agricultural work, military service, or aging:

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory cannabinoid exposure without psychoactive impairment (safe for operating farm equipment or driving to Savannah)
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD for pain [4], delta-9 THC for pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

For Bryan County residents struggling with the stress of military deployments, shift work at the port, or the quiet anxieties that come with rural living:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN — the dosage investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN — above the 20mg threshold associated with reduced sleep disturbance

Evidence: CBN sleep studies [16][17], cannabis and sleep review literature

Anxiety and Stress

For Bryan County veterans, first responders, and anyone carrying the weight of daily pressures:

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety pathways without impairment (perfect for maintaining productivity at work or managing family responsibilities)
• Nighttime: 1.0mL sublingual — full cannabinoid profile including CBN for sleep architecture

Evidence: CBD anxiety research [3], CBG pharmacology [7][8], limonene entourage effects [20]

General Titration Principle for Bryan County

Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications (especially if you’re taking prescriptions from Southeast Georgia Health System or VA prescriptions), and other factors unique to your physiology.

Delivery and Accessibility to Bryan County

Nationwide Shipping to Georgia

We ship directly to every address in Bryan County — from the riverfront homes in Richmond Hill to the rural routes outside Pembroke. All orders ship via USPS Priority Mail (2-3 business days), FedEx, or UPS Ground (3-5 business days).

Shipping Details:

• Discreet packaging: No cannabis branding visible externally
• Tracking: Provided for all orders
• Temperature-stable packaging: Essential for Georgia summers
• Signature-required option: Available for added security

International Shipping (Including from Bryan County to Overseas Military)

OilWell ships internationally and has delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because the product contains <0.3% delta-9 THC at point of sale, it meets the definition of a hemp product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

For Bryan County military families with loved ones deployed overseas: We can ship to APO/FPO addresses where local laws permit. All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes.

Customer Responsibility: International customers accept all customs and legal risk. Contact us: (832) 416-2816 or [email protected]

How to Order

Website: OilWellCBD.com

Phone: (832) 416-2816

Email: [email protected]

Business Hours:

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Media Recognition: Why Bryan County Can Trust OilWell

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin Valencia and OilWell Cannabis in seven distinct news segments. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter.

Why This Matters for Bryan County: Mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When you’re considering a purchase from a company you’ve never visited in person, knowing that a major news organization has vetted them repeatedly provides confidence.

ABC13 Feature Timeline

September 15, 2019 — Texas CBD Businesses Booming

• Reporter: Tom Abrahams
• Key Quote: Colin’s foundational philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
• Context: This quote is the seed of everything we do — our commitment to education over hype.

March 22, 2021 — Entrepreneur Creates Direct-to-Consumer Business

• Reporter: Tom Abrahams
• Key Quote: “Pain comes in a lot of different forms.”
• Context: Demonstrates our role as ecosystem builders helping other entrepreneurs enter legal cannabis.

May 24, 2021 — What is Delta-8 THC

• Reporter: Steve Campion
• Key Quote: When asked why someone would want Delta-8: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*
• Context: Radical honesty on mainstream television — a defining character moment.

August 20, 2021 — COVID Vaccine Giveaway

• Reporter: KTRK Staff
• Key Quote: “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”
• Context: OilWell gave away approximately $35,000 in product (1,000 caviar pre-rolls) to encourage vaccination. We coordinated with the city of Houston — real community action during a crisis.

October 19, 2021 — Texas Delta-8 Ban

• Reporter: Shelley Childers
• Key Quote: “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.”
• Context: When Texas classified Delta-8 as Schedule I overnight, Colin proactively removed all products and warned other operators who were unknowingly shipping illegal substances. Ethical leadership during a regulatory crisis.

October 7, 2022 — Biden Marijuana Pardon

• Reporter: Nick Natario
• Key Quote: “I would love to see people not get hurt for this anymore.”
• Context: This feature revealed that Colin has a personal marijuana conviction history. This transforms everything — every quote carries more weight knowing he’s lived the consequences.

April 21, 2023 — Marijuana Industry Renaissance

• Reporter: Nick Natario
• Key Quote: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”
• Context: Positions OilWell at the frontier of a changing industry.

The Through-Line: What Seven Features Reveal

Consistency across years: We appeared on ABC13 in 2019, 2021 (four times), 2022, and 2023. Through every shift in Texas law and cannabis culture, ABC13 returned to Colin as a primary source.

Breadth of expertise: Features span business, consumer health, product investigation, legal analysis, political commentary, and community advocacy.

Community action: Documented evidence of real investment in public health ($35,000 vaccine giveaway) and ethical leadership (proactive Delta-8 removal).

Personal stakes: Colin’s conviction history revealed in 2022 shows he’s not an outside entrepreneur but someone who’s lived the consequences and built a legal business with integrity.

Evolution of language: From “local wholesaler” in 2019 to “industry authority” by 2023, tracking credible growth.

For Bryan County: These features prove we’re not a fly-by-night operation. We’re a vetted, credible company that major media trusts for honest cannabis education.

The Science: GENERAL KNOWLEDGE Section

This section provides the evidence foundation for everything we claim about our products. We apply the same standards to our own formulas that we apply to the broader field.

Research Method and Evidence Weighting

We prioritize sources in this order:

1. Human clinical evidence
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Preclinical/mechanistic literature (when human data is sparse)

The evidence base is uneven: CBD and delta-9 THC have the strongest human literature. Delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and preclinical studies [1]-[29].

Institutional Baseline: What NIH and FDA Say

• Strongest established evidence: Rare epilepsies (Epidiolex), chemo nausea/vomiting, HIV/AIDS appetite loss
• Modest evidence: Chronic pain, multiple sclerosis symptoms
• FDA has NOT approved the cannabis plant itself for medical use
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, vape-related lung injury [1]

Cannabinoid Profiles

CBD (4,500mg in our formula)

• Strongest evidence: Seizure disorders — the major example acknowledged by institutional literature [1][2]
• Anxiety: 2024 systematic review shows statistically significant anxiolytic signal but limited clinical sample [3]
• Pain: 2024 review concludes literature is promising but heterogeneous, limiting broad analgesic claims [4]
• Sleep: 2023 review finds literature methodologically weak [5]
• Safety: 2023 review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially important for concentrated oral products and polypharmacy [6]
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications

CBG (3,000mg in our formula)

• Evidence: Mostly review-level and preclinical; human evidence sparse [7][8]
• Pharmacology: Biosynthetic precursor with distinct pharmacodynamics spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7]
• Research areas: Possible relevance to neurologic disorders, inflammatory bowel disease, antibacterial activity — but primarily pharmacology-led hypotheses [7][8]
• Caution: Commercially sold while evidence base remains thin [7]
• Bottom line: Promising minor cannabinoid with limited clinical validation

Delta-8 THC (6,000mg in our formula)

• Evidence: Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 [9]-[11]
• Pharmacology: Partial CB1 agonist with cannabimimetic activity, appears less potent than delta-9 due to weaker CB1 affinity [9]
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, and public health concerns rather than strong human trials [10]
• Manufacturing: Commercial interest tied to greater stability and easier synthesis [11]
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality concerns

THCa (1,500mg in our formula)

• Evidence: Important chemically, low on direct human therapeutic evidence [12]
• What it is: Acidic precursor of THC, may represent large share of THC-related content in raw plant material [12]
• Psychoactivity: Does not produce psychoactive effects IF it stays acidic, but decarboxylates to THC during heating and storage [12]
• Research: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not established human outcomes [12]
• Bottom line: Highly relevant precursor molecule whose interpretation depends on route, temperature, processing, storage

Delta-9 THC (90mg in our formula — LOW DOSE)

• Evidence: Strongest human evidence of psychoactive cannabinoids, clearest adverse-effect burden [1][13]-[15]
• Established uses: Chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes [1]
• Pain: 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation [13]
• Pharmacokinetics: Inhaled onset seconds-minutes, peak 15-30 minutes; oral onset later, peak later, duration longer [14]
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia and cannabis use disorder [15]
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, vape lung injury [1][14][15]
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities

CBN (750mg in our formula)

• Evidence: Weak human evidence; marketing ahead of data [12][16][17]
• Marketing vs. reality: Widely marketed for sleep/sedation, but clinical support far thinner than market suggests [16][17]
• Sleep literature: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found NO clinical trials using validated sleep questionnaires or polysomnography that substantiate strong sleep-promoting claims [16]
• Overall sleep research: 2024 review concluded cannabinoid sleep research doesn’t match real-world use scale, need for better-designed trials remains substantial [17]
• Bottom line: Clearest example where cultural reputation is stronger than current clinical evidence

CBC (750mg in our formula)

• Evidence: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19]
• Pharmacology: 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlights antinociceptive, antibacterial, anti-seizure areas as interesting [18]
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance [19]
• Safety: 2024 CBC review notes over-the-counter products sold despite little evidence establishing clinical efficacy or safety [18]
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active

Terpene Profiles

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene (citrus-bright)

• Evidence: Largely review and preclinical [20]-[22]
• Potential: 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory properties — but mostly from nonhuman/non-cannabis literature [21]
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22]
• Bottom line: Biologically active, but cannabis-specific therapeutic claims should stay conservative [20]-[22]

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23]
• Research: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, but explicitly states human studies lacking [23]
• Caution: Often invoked as proven sedative explaining “couch-lock” — stronger claim than human evidence supports [20][23]
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims remain far ahead of definitive human proof

Caryophyllene (β-caryophyllene — pepper/spice)

• Evidence: Among most mechanistically interesting due to CB2 receptor relevance, but mostly preclinical [24]
• Why it stands out: 2021 review describes as selective CB2 receptor agonist — unusual and especially relevant for pharmacologic discussion [24]
• Research: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective discussed, but human clinical confirmation limited [24]
• Bottom line: Strongest candidate for terpene with cannabinoid-system significance, but not clinically proven for outcomes commonly attributed

Pinene (forest-fresh)

• Evidence: Promising preclinical, weak human confirmation [20][25]
• Brain health: 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25]
• Caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain hypotheses, not settled facts [20][25]
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory

Linalool (floral, lavender)

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]
• Research: Discussed in relation to stress, mood, brain health. 2021 brain-health review found enough preclinical signal to justify investigation, but emphasized lack of robust human trials [25]
• Additional: Separate reviews discuss antidepressant mechanisms, neuropharmacologic relevance, but remain translational [26]
• Safety: Oxidized linalool hydroperoxides are recognized allergens [22]
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing

Humulene (earthy, woody)

• Evidence: Translationally interesting, but early [20][27]
• Scoping review: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]
• Caution: Findings valuable for hypothesis generation, not yet establishing consistent human efficacy [27]
• Bottom line: More interesting terpene research target, but far from clinically settled

Terpinolene (piney, fruity, sparkling)

• Evidence: Least clinically characterized in this file [20][28]
• Systematic review: 2021 review screened 2,449 records, included 57 studies, concluded evidence base dominated by in silico, in vitro, animal studies [28]
• Bottom line: Biologically interesting, but especially underdeveloped clinically

Research Limits and Common Overstatements

Five critical interpretation rules:

1. Evidence is highly uneven (CBD/delta-9 THC strongest)
2. Extract/molecule/synthetic/terpene data aren’t interchangeable
3. Minor cannabinoids are commercially interesting BECAUSE underexplored
4. Product quality matters as much as molecule identity
5. THCa chemistry changes with storage/heating

Overstatements to Avoid:

Overstatement	More Accurate Version
CBN is a clinically proven sleep aid	Specific sleep evidence for CBN remains weak, no strong validated trial base [16][17]
Myrcene is a proven human sedative	Human proof for sedation claim is limited [20][23]
Terpenes have proven entourage effects	Robust clinical proof remains limited and compound-specific [20][29]
THCa is always non-psychoactive	Heating converts THCa to THC, changing effective exposure [12]
Delta-8 is safe because hemp-derived	Delta-8 is psychoactive, less characterized than delta-9, with manufacturing concerns [9]-[11]

The Broader OilWell Product Portfolio

Beyond RSO, we produce a range of cannabinoid products, each developed from the formulation knowledge Colin built over Bentley’s ten-year journey and his own experience with PTSD and benzo withdrawal.

“The Asshole” Peach Gummy Rings — $39.99

• 268mg total cannabinoids per ring: 28mg Delta-9 THC, 50mg Delta-8 THC, 20mg Delta-10 THC, 20mg THCo, 100mg CBD, 50mg CBG
• Particularly favored by veterans for PTSD and pain relief

Peace Gummy Peaches — $34.99

• 320mg total cannabinoids per peach: 30mg CBN, 15mg Delta-9 THC, 25mg Delta-8 THC, 100mg CBD, 150mg CBG
• Developed from Colin’s personal benzo withdrawal experience
• Also available in vape form for quick relief

SWEETEMintz Sugar-Free Vegan Peppermint Hard Candy — $39.99

• 28mg Delta-9 Nano THC, 100mg Nano CBD, 50mg CBG Isolate
• Zero sugar, 100% vegan — designed for diabetic and health-conscious consumers

Custom Creations: We design tailored products on request for specific cannabinoid ratios, delivery formats, or health circumstances including formulations for vegans, diabetics, and those with specific dietary needs.

How Our Formulas Connect to The Evidence

Every cannabinoid and terpene in our formulas has its own evidence profile in the GENERAL KNOWLEDGE section. We anchor our claims to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field.

Where our RSO guide makes specific research claims, this document provides the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework.

Our position is simple: You deserve the best possible version of the information so you can give it a fair shot and decide for yourself whether it’s right or wrong for you.

Frequently Asked Questions for Bryan County Residents

Q: Is this legal to order and possess in Bryan County, Georgia?
A: Yes. Our products contain less than 0.3% delta-9 THC and are hemp-derived, making them legal under the 2018 Farm Bill and Georgia’s Hemp Farming Act. We ship discreetly with full documentation.

Q: Will this show up on a drug test if I work at the Port of Savannah or Fort Stewart?
A: Delta-8 THC and activated delta-9 THC will trigger positive drug tests. If you use the raw (non-decarboxylated) sublingual oil, THCa itself is not delta-9 THC and should not trigger a standard THC test. However, ANY psychoactive use carries employment risk. Consider your workplace policies carefully.

Q: How long does shipping take to Richmond Hill/Pembroke?
A: Typically 2-3 business days via USPS Priority Mail. All packages are discreetly packaged with no cannabis branding.

Q: Can I take this while on medications from my doctor in Savannah?
A: CBD and other cannabinoids can interact with medications. Consult your prescribing physician before use, especially if you take blood thinners, anti-seizure medications, or other drugs metabolized by the liver.

Q: Is this the same as what I’d get at a dispensary in Georgia?
A: No. Georgia dispensaries sell Low-THC oil (maximum 5% THC) to registered medical patients. Our product is completely different — multi-cannabinoid, hemp-derived, no medical card required. The THCa can be activated at home to produce full-potency effects legally.

Q: What if I can’t afford $129.99?
A: We publish our complete formula. You can source individual cannabinoid distillates and make your own version. This is our open-source commitment — no one in Bryan County is shut out.

Q: How do I know your product is safe?
A: We provide third-party Certificates of Analysis (COAs) for every batch testing for: cannabinoid potency, terpenes, pesticides (400+ compounds), heavy metals (arsenic, cadmium, lead, mercury), residual solvents, and microbial contaminants. No traditional RSO maker can match this.

Q: Will this help with my specific condition?
A: We provide evidence-based context for various conditions, but we cannot and do not make medical claims. Individual results vary. Consult your healthcare provider.

Safety and Legal Disclaimers

Age Requirement: 21+ to purchase RSO products.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Safety Warnings: May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Consult a physician if pregnant or nursing. Keep out of reach of children. May interact with medications. Consult your healthcare provider before use.

Legal Notice: Buyer is responsible for verifying and complying with all local, state, and federal laws regarding purchase, possession, and use of cannabinoid products. OilWell ships with full documentation and COAs. Customer assumes all legal responsibility for use and any home decarboxylation decisions. Void where prohibited by law.

For Bryan County Residents: Georgia law prohibits recreational marijuana. Our products are hemp-derived and Farm Bill compliant. Activating THCa through home decarboxylation creates delta-9 THC, which may affect legal status. Understand your local laws before proceeding.

Connect With Us

Website: OilWellCBD.com

Phone: (832) 416-2816

Email: [email protected]

Instagram: @oilwellcbd

Address: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

Hours: Monday-Thursday 10AM-7PM, Friday-Saturday 10AM-10PM, Sunday 10AM-4PM

Final Thoughts for Bryan County

From the banks of the Ogeechee to the neighborhoods of Richmond Hill, from the farmlands of Pembroke to the gates of Fort Stewart — Bryan County is a community that understands perseverance. We built OilWell on that same foundation: a refusal to give up when conventional options fail, a commitment to honest education over hype, and a belief that everyone deserves access to thoughtfully formulated cannabinoid medicine.

Rick Simpson started a movement by giving his oil away for free. We’re continuing that legacy by giving away something just as valuable: the complete truth about what works, what doesn’t, and what the science actually says.

Whether you’re a cancer patient looking for supportive care, a veteran seeking PTSD relief, a farmer managing chronic pain, or simply curious about what cannabinoids might do for you — we’re here. No snake oil. No false hope. Just the best possible version of the information, so you can give it a fair shot and decide for yourself.

Because in Bryan County, we don’t just endure — we figure out what works.

Complete Reference List

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Rick Simpson References:
RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024.